Analysis of hepatic hemodynamic adjustments is made peculiarly difficult by the complexity of the splanchnic circulation. Blood flow through the liver appears to be controlled by the interactions between four sets of vascular resistances: (a) those imposed between the aorta and the portal vein including the splenic, gastric, mesenteric, and colic arterioles; (b) those between the aorta and the sinusoids, the hepatic arterioles; (c) those between the portal vein and the sinusoids, the portal venules; and (d) those between the sinusoids and the hepatic veins. During the development of cirrhotic disease of the liver a fifth set of resistances between the portal vein and the inferior vena cava, i.e., the collateral circulation, becomes important in determining blood flow. The portal venous pressure and the sinusoidal pressure are, likewise, resultants of the interaction of these resistances and arterial pressure. A change in any one resistance alone will induce various changes in the rate of blood flow through all the others and will affect the pressures in both the portal vein and sinusoids. In the absence of quantitative data regarding these factors, therefore, any discussion of the dynamics of splanchnic flows and pressures must be guarded. Nevertheless, it has seemed reasonable to believe that portal hypertension develops during cirrhotic disease (initially, at least) as a result of increased resistance to portal venous flow into the liver. Hence the reduction in hepatic blood flow (3)
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2Fellow of the American College of Physicians. Present address: Naval Medical Field Laboratory, Camp Lejeune, North Carolina. 8 Visiting Scholar in Surgery. Present address: Dept. of Surgery, University of Edinburgh, Edinburgh, Scotland. demonstrable under these circumstances is presuniably to some extent a measure of the reduction in portal venous inflow. The fact that the hepatic venous oxygen content is reduced in cirrhosis (3) suggests further that the portal venous blood provides a substantial portion of the oxygen supply to the liver in man.
Although these views may not be subjected to experimental evaluation in human subjects, the recent development of effective surgical procedures for the treatment of portal hypertension offers an alternative approach. Portacaval or splenorenal venous anastomosis permits the escape of blood from the engorged portal vein into the systemic venous system and lowers portal venous pressure (4, 5) . The resulting reduction in portal inflow should reproduce or exaggerate the hepatic hemodynamic changes of cirrhosis mentioned above if these are due to portal venous obstruction. In addition, it is possible to determine the oxygen content of portal venous blood withdrawn several days post-operatively through a catheter left in place to permit local infusion of heparin. Measurements of hepatic blood flow and oxygen uptake were therefore made before and after portacaval anastomosis in patients with cirrhosis of the liver.
METHODS
The subjects of this study were 12 patients with wellestablished portal hypertension and cirrhosis of the liver. Eleven had suffered repeated blood loss from ruptured esophageal varices and one presented herself with intractable ascites which had failed to respond to prolonged medical management. In all, biopsies of the liver provided definite evidence of cirrhosis. A resume of the more important data obtained in the clinical study of each patient is appended (Addenda). A history of excessive alcohol intake was obtained in only two individuals (T. K. and E. K.). In seven (K. N., P. P., C. M., N. D., A. R., K. O'D., and S. W.) it seemed likely that the cirrhotic process had its inception in some variety of hepa- blood divided by concentration in arterial blood); RB8P = rate of disappearance of BSP from the blood (taken as hepatic removal rate); and EHBF = estimated hepatic blood flow.
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titis. Disease of the biliary tract may have been important in two of these, (K. N. and P. P.). In the remainder, the cause of cirrhosis and portal venous hypertension was uncertain. Extra-hepatic portal venous obstruction may have played a role in P. N. and P. McC. In the latter, however, the portal venous thrombosis encountered at the time of portacaval anastomosis may have developed as a result of an earlier splenectomy. The changes in liver function ranged widely and showed no consistent pattern in the group as a whole. In five patients (P. N., P. P., T. K., K. N., and H. C.) the spleen was removed and an end-to-side anastomosis established between the splenic vein and the left renal vein. The portal vein and the inferior vena cava were united in three (P. McC., N. D., and E. K.) by an end-to-side anastomosis and in two (A. R. and S. W.) by a side-to-side anastomosis. At the time of operation the shunt functioned efficiently in all and it appeared to be patent at the time of study following operation with one possible exception (K. O'D.). The term "portacaval anastomosis" will be used throughout this paper as a general expression indicating any one of these three shunting operations. All subjects *ere fasting and resting quietly in recumbency at the time of study from one to 80 days preoperatively and within less than six weeks post-operatively in 10, seven months in one (K. O'D.) and 30 months in another (K. N.) (see Addenda).
The hepatic blood flow (EHBF) was estimated by the bromsulfalein (BSP) method (6) (8) . The venous oxygen concentrations were corrected, when necessary, for inadvertent dilution by the dextrose (5 per cent) or saline solution with which the catheters were perfused to prevent obstruction by clotting. This correction was made on the basis of the arterial oxygen capacities (6) .
RESULTS
The results of these studies are tabulated in Tables I to III . The values necessary for the calculation of estimated hepatic blood flow (EHBF Table I ) were taken at the time in each study when the plasma BSP concentration (PBSP) was change A more detailed account of the clinical status of each of these patients was deemed unnecessary because measurements of hepatic blood flow and oxygen uptake were not made. Each had undergone portacaval anastomosis for the treatment of persistent portal hypertension and was recovering uneventfully at the time of study.
ing least (the rate of change is recorded in the (Table  I) . It decreased in every instance post-operatively, falling on the average to 845 ± 284 ml. per minute with a range of 480 to 1,490 ml. per minute. The difference between the values obtained before and after operation was highly significant, amounting to more than five times the standard error of the difference (relative deviate, dev./S.E., or the ratio between the difference between the means and the standard error of the difference = 5.2). The percentage decrement in EHBF ranged from 9 to 62 per cent. No correlation between this change and the magnitude of the preoperative figure was demonstrable. These data were insufficient to permit accurate evaluation of the type of surgical procedure in terms of its effect on EHBF. However, the largest reductions (S. W., 62 per cent; A. R., 49 per cent) occurred following side-to-side portacaval anastomosis and the smallest following splenorenal venous anastomosis (P. P., K. N., P. N., H. C., and T. K.). Measurements of EHBF were made on two separate occasions prior to portacaval anastomosis in two patients (P. N. and P. P.), in one of whom (P. N.) the values were obtained before and after an unsuccessful attempt to establish a shunt. Although an anomalous portal vein was ligated and transected at the first operation, EHBF changed from 1,220 to 1,890 ml. per minute and then fell to 880 ml. per minute following the second operation. It may be concluded that portal venous blood continued to perfuse the liver in P. N. under high pressure until completion of the shunting procedure. In P. P., EHBF, determined four and two months pre-operatively, amounted to 960 and 1,080 ml. per minute. Unfortunately additional data of this kind were not obtainable but it seems unlikely that spontaneous changes in EHBF can account entirely for the alteration following portacaval anastomosis.
Hepatic extraction of bromsulfalein
In association with the fall in EHBF the hepatic extraction of bromsulfalein (EBSP) increased in six patients and remained relatively unchanged in four (P. McC., N. D., T. K. and E. K., Table I ). On the average EBSP rose from 26.5 ± 12.9 per cent to 42.9 + 12.5 per cent, a highly significant change (dev./S.E. = 3.7).
Bromsulfalein extraction has been shown (11), in general, to vary inversely with the blood level in normal subjects and the same tendency was demonstrable in this series pre-operatively (Table  I) . In order to avoid changes in extraction attributable to a change in PBSP rather than blood flow and/or hepatocellular activity, an effort was made to make measurements at the same BSP concentration before and after operation. and 0.86 mg. per cent, respectively.) In the remainder of the subjects, any alteration in EBSP after portacaval anastomosis may be considered to have occurred independently of a change in PB8P.
The plasma concentration of BSP also tended to vary inversely with estimated hepatic blood flow pre-operatively (Table I ). The plasma level of BSP is largely a function of the amount infused and the ability of the liver to eliminate it. In normal persons (3), 4 to 6 mg. of BSP must be infused each minute to maintain PBSP at levels equal to those attained in this investigation. The low infusion rate used here, indicated by the removal rate (RBsp -Table I ), resulted in a low PBSP in those patients with relatively good function and in high values in those with a reduced capacity to remove the dye. Thus, the apparent inverse correlation between PBsP and EHBF may be regarded simply as the result of the variation in the degree of liver damage. This view is borne out by the sequel. Since the plasma levels were kept at approximately the same values after operation while EHBF and EBSP changed in opposite directions, the correlation was no longer demonstrable. Bromsulfalein extraction presented much less percentage variation post-operatively despite the same range in PBSP.
Hepatic oxygen uptake
The hepatic arteriovenous oxygen difference increased following portacaval anastomosis in 9 of the 12 patients in whom it was measured (Table II) , increasing on the average in the group as a whole from 4.1 ± 0.6 to 5.8 + 1.5 ml. per 100 ml. blood. The difference between the pre-operative and post-operative values was statistically significant (dev./S.E. = 3.8). The change could be entirely accounted for by a fall in the oxygen content of hepatic venous blood. Possibly the shunt was not operating effectively in the two subjects (E. K. and K. O'D.) in whom the hepatic arteriovenous oxygen difference decreased, but this possibility cannot be substantiated on the basis of the available data. In P. N. and P. P., the hepatic arteriovenous oxygen difference changed from 4.2 to 3.6 ml. per 100 ml. blood, and from 4.9 to 6.1 ml. per 100 ml. blood, respectively, in the two control measurements made before portacaval anastomosis and in each it increased after the shunt had been established, to 6.8 and 8.4 ml. per 100 ml. blood, respectively. Calculation of total "hepatic oxygen uptake" from simultaneously determined values for EHBF and hepatic arteriovenous oxygen difference yielded figures (average, 50.9± 13.9 ml. per minute, Table II ) which agreed with those obtained in other patients with cirrhosis (3). There was no significant change post-operatively indicating an inverse correlation between EHBF and hepatic arteriovenous oxygen difference. It must be emphasized that this calculation of the "hepatic oxygen consumption" provides at best an estimate of the true value. An undetermined volume of oxygen has been removed from the portal blood which contributes to the total hepatic venous outflow.
In normal individuals the calculation presumably yields a value for total splanchnic oxygen consumption but in cirrhosis a significant and unmeasured proportion of the portal blood is diverted from the liver through collateral channels. Failure to correct for the lower oxygen content of portal venous blood results in falsely high values for the hepatic oxygen arteriovenous difference and for the hepatic oxygen uptake, whereas failure to allow for di-version gives rise to falsely low values for splanchnic oxygen consumption.
Measurement of the oxygen content of portal venous blood obtained in 11 patients (including two [E. K. and H. C.] in whom EHBF had been determined) revealed a relatively high concentration in resting patients. The arterial-portal vein oxygen difference averaged 2.0 + 0.79 ml. per 100 ml. blood (Table III) . Hence the error introduced in the calculation of the hepatic oxygen consumption by the failure to correct for portal venous oxygen levels is probably small, particularly in patients with cirrhosis in whom portal flow contributes less to total hepatic blood flow than in normal persons.
DISCUSSION
Since portal venous pressure decreased in every instance at operation immediately after opening the portacaval shunt (see Addenda) it seems reasonable to attribute the fall in EHRF observed as long as two years post-operatively to a persistent reduction in portal venous pressure. The fall in EHBF may therefore be considered a reflection of diminished hepatic portal inflow modified to some extent perhaps by secondary changes in hepatic arteriolar resistance and hepatic arterial inflow. Such an interpretation is based upon the belief that portal hypertension is a consequence of increased resistance to flow through the portal venous system within the cirrhotic liver. Recent work (12, 13) suggests that this view may be inadequate.
Myers and Taylor (12) The absence of a significant reduction in estimated hepatic oxygen consumption appears to indicate that relatively little oxygen is removed from the portal venous blood by extrahepatic tissues and measurement of the portal venous oxygen content bears out this interpretation. It could be argued that the small difference between arterial and portal venous oxygen concentrations, noted in this and other studies (15, 16) , indicates retrograde flow of hepatic arterial blood into the portal system. The fact that the highest value (E. K., 3.4 ml. per 100 ml. blood- Table III) was obtained in a patient who had undergone end-to-side portacaval anastomosis with ligation of the portal vein could be brought forward to support such a thesis. However, in the only other person in whom portal venous oxygen content was measured following an end-to-side portacaval shunt, the arteriovenous difference was quite low (J. L., 1.0 ml. per 100 ml. blood). It is more likely that reflux of blood from the inferior vena cava occurred in E. K. during sampling, giving rise to a falsely low value for portal venous oxygen content. Hence it may be concluded that a substantial portion of the oxygen supply to the liver is derived from the portal venous inflow in cirrhosis. But since portal flow makes up only one-quarter of the total blood flow through the liver (if the decrement in EHBF is a measure of the portal contribution) it is evident that the hepatic arterial inflow accounts for a major portion of the liver's oxygen supply. Ligation of the hepatic artery in cirrhotic patients to lower portal venous pressure may therefore critically reduce the delivery of oxygen to hepatic tissues.
Although quantitative evaluation of the hemodynamic factors controlling blood flow through the cirrhotic liver is not feasible at present, owing to lack of information regarding simultaneous pressures and rates of flow in the different components of the splanchnic vasculature, a provisional qualitative appraisal seems permissible. The hepatic blood flow appears to be reduced in cirrhotic disease solely as a result of interference with portal venous inflow, presumably as a result of increased resistance to flow through both portal and hepatic venules. Hepatic arterial inflow does not increase sufficiently, if it changes at all, to compensate for this defect. The hemodynamic changes in cirrhosis appear to be of secondary rather than primary importance, since the exaggeration of the fundamental circulatory derangement following portacaval anastomosis does not appear to intensify or accelerate the underlying disease process. SUMMARY 1. Estimated hepatic blood was measured by the bromsulfalein method in 10 patients with cirrhotic disease and hepatic arteriovenous oxygen difference in 12, before and after establishment of a portacaval shunt (end-to-side portacaval anastomosis in three, side-to-side portacaval anastomosis in two, and by end-to-side splenorenal venous anastomosis in five). The oxygen content was determined in portal venous blood withdrawn several days postoperatively through a catheter left in place for regional heparinization in 12 patients.
2. Estimated hepatic blood flow (EHBF) decreased following anastomosis in every instance, from 1,266 ± 282 ml. per minute to 845 + 284 ml. per minute on the average, a highly significant difference. Bromsulfalein extraction increased in six and remained relatively unchanged in four patients, changing significantly on the average from 26.5 ± 12.9 per cent to 42.9 ± 12.5 per cent. The hepatic arteriovenous oxygen difference increased in 9 of 12 subjects, from 4.1 + 0.6 to 5.8 ± 1.5 ml. per 100 ml. blood on the average. Although mean hepatic arteriovenous oxygen difference increased significantly, estimated hepatic oxygen consumption was not affected. The arterialportal venous oxygen difference ranged from 1.1 to 3.4 ml. per 100 ml. blood and averaged 2.0 ± 0.79.
3. The fall in hepatic blood flow post-operatively is apparently attributable to diversion of portal venous blood from the liver directly into the systemic venous system. The slower perfusion of the liver without significant change in total oxygen consumption and BSP removal by the liver resulted in augmented extraction of oxygen and BSP. (Tables I and II) were made on 22 September 1947. At operation on 10 October 1947 a "hobnail" liver and an enlarged spleen were found. After splenectomy, an end-to-side anastomosis was made between the splenic and left renal vein; the portal venous pressure fell from 210 to 200 mm. saline. She recovered uneventfully and within four months all the abnormalities noted in the laboratory study had cleared. Ascites did not recur after one month, and she gained more than 30 pounds in the next year. Measurements of EHBF and hepatic oxygen uptake (Tables I and II) Hospitalization and study at this time revealed no apparent cause but an enlarged spleen was discovered following a second massive hematemesis one year later (1945) and splenectomy was performed. The liver was described as "moderately cirrhotic." Hematemesis recurred on more than five occasions thereafter, requiring repeated transfusions. Esophagoscopy (1948) revealed large esophageal varices which were injected with a sclerosing solution without affecting the course. There was no evidence in the history of jaundice, exposure to hepatotoxins or excessive intake of alcohol. The physical examination revealed no obvious abnormality. The laboratory findings were as follows: serum bilirubin, 1.0 mg. per cent; alkaline phosphatase, 4.0 B.U.; cholesterol, 285 mg. per cent (77 per cent esters); serum protein, 7.6 gm. per cent (A/G-4.9/2.7); negative cephalin-cholesterol flocculation and thymol turbidity; and normal BSP retention. X-ray examination revealed unusually large esophageal varices. The hepatic function studies described above (Tables I and II) were made on 23 November 1949. At operation on 29 November 1949 the liver was somewhat irregular in shape and smaller than normal and the portal vein was partially occluded by an old well-organized thrombus. An end-to-side anastomosis was made between the portal vein and the inferior vena cava, the portal pressure decreased from 620 to 540 mm. saline after the shunt was opened. Biopsy of the liver revealed thickening of the capsule, moderate distortion of the parenchymal architecture by bands of connective tissue extending between the portal spaces. Convalescence was complicated by several hematemeses which ceased following cauterization of an ulcer of the nasal septum. The hepatic function studies were repeated (Tables I and II) (Tables I  and II) were measured on 8 January 1951. Following a side-to-side portacaval anastomosis on 1 February 1951, the portal venous pressure fell from 300 to 100 mm. saline. The liver was enlarged and hard, microscopic examination revealed marked distortion of the architecture by anastomosing fibrous cords. Convalescence was uneventful and hepatic function studies (Tables I and II) (Tables I and II) . Following an end-to-side portacaval anastomosis on 14 December 1950 the portal venous pressure fell from 580 to 220 mm. saline. The liver was small, nodular, and firm; microscopic examination revealed bands of connective tissue dividing the parenchyma into variously sized lobules. Convalescence was uneventful and a post-operative hepatic venous catheterization was performed on 20 December 1950 (Tables I and II) . Within a few months after operation the patient had returned to an active life and all abnormal laboratory findings had reverted to normal (7 May 1952 At the age of five years she suffered a febrile illness and jaundice from which she seemed to recover completely. However, slight jaundice recurred from time to time in association with upper respiratory infections during the years that followed. In 1948 jaundice and ankle edema appeared and persisted. At this time hepatosplenomegaly and "spider" angiomata were noted. Laboratory study (January 1949) revealed the following: serum bilirubin, (Table  II) . On 7 March 1950 splenectomy followed by endto-side splenorenal venous anastomosis was performed. Biopsy of the liver at this time disclosed marked distortion of the parenchyma by broad bands of connective tissue containing many small bile ducts and lymphocytes. Convalescence was complicated by massive atelectasis of the right upper lobe. A second hepatic venous catheterization was performed on 13 October 1950 (Table II) . She has done well since operation, the jaundice and edema having cleared completely. The cephalin-cholesterol flocculation is now negative but the serum cholesterol and alkaline phosphatase remain elevated. Bromsulfalein excretion is still greatly impaired. She has gained weight and feels well. 
